Ratings Franklin Resources, Inc.

Equities

BEN

US3546131018

Real-time Estimate Cboe BZX Other stock markets 11:12:11 2024-04-26 am EDT			5-day change	1st Jan Change
25.06 ^USD	-0.14%		-0.04%	-15.61%

Apr. 22	Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors	CI
Apr. 17	TD Cowen Cuts Price Target on Franklin Resources to $29 From $30	MT

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The company returns high margins, thereby supporting business profitability.
The company is in a robust financial situation considering its net cash and margin position.
The company's attractive earnings multiples are brought to light by a P/E ratio at 12.21 for the current year.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
This company will be of major interest to investors in search of a high dividend stock.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Investment Management & Fund Operators

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
FRANKLIN RESOURCES, INC.	-15.61%	13.21B		C+
BLACKSTONE INC.	-6.30%	89.1B		C-
KKR & CO. INC.	+15.73%	83.96B		C+
ARES MANAGEMENT CORPORATION	+13.72%	26.03B		B-
LEGAL & GENERAL PLC	-6.48%	17.21B	-	B+
AMUNDI	+7.39%	13.87B		B
HDFC ASSET MANAGEMENT COMPANY LIMITED	+16.00%	9.45B		B
BLUE OWL CAPITAL INC.	+26.14%	8.65B		C-
LUMINE GROUP INC.	+25.92%	6.92B	-	-
INFRATIL LIMITED	+8.57%	5.38B		D+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes